Filing Details

Accession Number:
0001535264-21-000051
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-15 16:42:51
Reporting Period:
2021-12-13
Accepted Time:
2021-12-15 16:42:51
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1588972 Recro Pharma Inc. REPH () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1535264 Awm Investment Company, Inc. 527 Madison Avenue
Suite 2600
New York NY 10022
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-12-13 20,000 $1.63 5,261,901 No 4 S Indirect By Limited Partnerships
Common Stock Disposition 2021-12-14 10,602 $1.57 5,251,299 No 4 S Indirect By Limited Partnerships
Common Stock Disposition 2021-12-15 20,000 $1.63 5,231,299 No 4 S Indirect By Limited Partnerships
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Limited Partnerships
No 4 S Indirect By Limited Partnerships
No 4 S Indirect By Limited Partnerships
Footnotes
  1. This is a weighted average price.
  2. AWM Investment Company, Inc., a Delaware Corporation (AWM), is the investment adviser to Special Situations Fund III QP, L.P. (QP), Special Situations Cayman Fund, L.P. (Cay) and Special Situations Private Equity Fund, L.P. (PE). (PE together with QP and Cay the Funds). As the investment adviser to the Funds, AWM holds sole voting and investment power over 3,265,741 shares of Common Stock of the Issuer (the Shares) held by QP, 1,140,727 Shares held by Cay and 824,831 Shares held by PE.
  3. Austin W. Marxe (Marxe), David M. Greenhouse (Greenhouse) and Adam C. Stettner (Stettner) are the controlling principals of AWM.The reporting person disclaims beneficial ownership of the Shares, except to the extent of its pecuniary interest therein. This report shall notbe deemed an admission that the reporting person is the beneficial owner of the securities reported herein for purposes of Section 16 of theSecurities Exchange Act of 1934, as amended, or for any other purpose.